Source: American Academy of Neurology
05.22.2007
Cancerous brain tumors appear to respond favorably to the drug temozolomide when used as primary chemotherapy after surgery, and the treatment appears to work best in people missing a certain gene, according to a study published in the May 22, 2007, issue of Neurology®, the scientific journal of the American Academy of Neurology.
External Link: http://www.aan.com/press/index.cfm?fuseaction=release.view&r...
